Cardiac Troponin Elevation Predicts Mortality in Patients Undergoing Orthotopic Liver Transplantation

Table 2

Comparisons of types of liver disease.

	All patients	Troponin
		Negative	Intermediate	Elevated
Primary liver disease (𝑛)	78	42	28	8
Alcohol	10 (12.8%)	5 (11.9%)	2 (7.1%)	3 (37.5%)
Hepatitis C	30 (38.5%)	19 (45.2%)	9 (32.1%)	2 (25.0%)
NASH	11 (14.1%)	5 (11.9%)	4 (14.3%)	2 (25.0%)
PBC	5 (6.4%)	2 (4.8%)	3 (10.7%)	0 (0.0%)
PSC	5 (6.4%)	4 (9.5%)	1 (3.6%)	0 (0.0%)
Acetaminophen	1 (1.3%)	1 (2.4%)	0 (0.0%)	0 (0.0%)
Cryptogenic	13 (3.9%)	6 (14.3%)	6 (21.4%)	1 (12.5%)
Polycystic	2 (2.6%)	0 (0.0%)	2 (7.1%)	0 (0.0%)
Autoimmune	1 (1.3%)	0 (0.0%)	1 (3.6%)	0 (0.0%)
Secondary liver disease (𝑛)	19 (24.4%)	13 (31.0%)	5 (17.9%)	1 (12.5%)
Alcohol	3 (15.8%)	2 (15.4%)	1 (20.0%)	0 (0.0%)
Hepatitis C	1 (5.3%)	0 (0.0%)	1 (20.0%)	0 (0.0%)
HC	15 (78.9%)	11 (8.5%)	3 (60.0%)	1 (100.0%)

NASH: nonalcoholic steatohepatitis; PBC: primary biliary cirrhosis; PSC: primary sclerosing cholangitis; acetaminophen: acetaminophen toxicity; HC: hepatocellular carcinoma.